作者: Sven O. Eicker , Kerim Beseoglu , Nima Etminan , Jason Perrin , Arzu Taskin
DOI: 10.1007/978-3-7091-0956-4_62
关键词:
摘要: Objective: The current clinical prospective randomized phase II study was initiated in order to analyze the effect of enhanced washout by discontinuous intraventricular thrombolysis combination with low-frequency head-motion therapy on side effects, clot clearance rate, cerebral vasospasm and outcome after severe subarachnoid hemorrhage (SAH).